Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpArizona GOP Senate candidate defends bus tour with far-right activist Alyssa Milano protests Kavanaugh in 'Handmaid's Tale' costume Bomb in deadly Yemen school bus attack was manufactured by US firm: report MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinDems to challenge Kavanaugh for White House records 2020 hopefuls skeptical of criminal justice deal with Trump Sentencing reform deal heats up, pitting Trump against reliable allies MORE (D-Ill.), Kirsten GillibrandKirsten Elizabeth GillibrandGillibrand: 'Solely focused' on 2018, not potential 2020 White House bid Sunday shows preview: Trump stokes intel feud over clearances Boogeywomen — GOP vilifies big-name female Dems MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanSenate panel spars with Trump administration over treatment of unaccompanied immigrant children Dem senators introduce resolution calling on Trump to stop attacking the press Senators blast Michigan State president's handling of sex abuse scandal MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownThe Hill's Morning Report — Trump’s GOP feuds dominate ahead of midterms Dustbin 2020: The best Dems who surely won’t get the nomination Vulnerable Dems side with Warren in battle over consumer bureau MORE (D-Ohio) and Angus KingAngus Stanley KingOvernight Energy: Judge revives clean water rule | Keystone XL pipeline to get new environmental review | Nominee won't say if he backs funding agency Trump nominee won't say if he supports funding agency he was selected to run Trump draws bipartisan fire over Brennan MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.